Abstract
Iron chelating drugs can impede the rapid reproduction of tumor cells. Among these drugs, deferasirox (DEF) have shown antitumor properties and therefore been selected for this study. The aim of this study was preparation and characterization of the bifunctional polymeric nanoparticles (NPs) by targeting moieties which is applied in cancer.
Therefore, DEF NPs were fabricated by exploiting of PLGA-PEG-FOL conjugate and combination of sonication and emulsification/solvent evaporation technique. Then the influence of important factors including the amount of vitamin E TPGS as a safe surfactant and the ratio of drug to polymer in organic phase was evaluated. Some formulations showed suitable size distribution below 200 nm with high drug entrapment. Drug release study indicated sustained release profile of DEF encapsulated in NPs. Stability study showed acceptable condition for preserving the formulation during six months.
Keywords: Bifunction, deferasirox, drug delivery, nanotechnology, PLGA-PEG-folate.
Nanoscience & Nanotechnology-Asia
Title:Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox
Volume: 4 Issue: 2
Author(s): Mina Mir and Pedram Ebrahimnejad
Affiliation:
Keywords: Bifunction, deferasirox, drug delivery, nanotechnology, PLGA-PEG-folate.
Abstract: Iron chelating drugs can impede the rapid reproduction of tumor cells. Among these drugs, deferasirox (DEF) have shown antitumor properties and therefore been selected for this study. The aim of this study was preparation and characterization of the bifunctional polymeric nanoparticles (NPs) by targeting moieties which is applied in cancer.
Therefore, DEF NPs were fabricated by exploiting of PLGA-PEG-FOL conjugate and combination of sonication and emulsification/solvent evaporation technique. Then the influence of important factors including the amount of vitamin E TPGS as a safe surfactant and the ratio of drug to polymer in organic phase was evaluated. Some formulations showed suitable size distribution below 200 nm with high drug entrapment. Drug release study indicated sustained release profile of DEF encapsulated in NPs. Stability study showed acceptable condition for preserving the formulation during six months.
Export Options
About this article
Cite this article as:
Mir Mina and Ebrahimnejad Pedram, Preparation and Characterization of Bifunctional Nanoparticles of Vitamin E TPGS-emulsified PLGA-PEG-FOL Containing Deferasirox, Nanoscience & Nanotechnology-Asia 2014; 4 (2) . https://dx.doi.org/10.2174/2210681205666150515000224
DOI https://dx.doi.org/10.2174/2210681205666150515000224 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Clinical Application of Ghrelin
Current Pharmaceutical Design Characterization of the Prostaglandin E2 Pathway in a Rat Model of Esophageal Adenocarcinoma
Current Cancer Drug Targets Hypofractionated Radiotherapy in Non Small Cell Lung Cancer: A Review of the Current Literature
Reviews on Recent Clinical Trials 30 Years Lost in Anesthesia Theory
Cardiovascular & Hematological Agents in Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines
Anti-Cancer Agents in Medicinal Chemistry Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine
Current Pharmaceutical Design Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Strategy for the Treatment of Helicobacter pylori Infection
Current Pharmaceutical Design Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry Latest Results for Anti-Angiogenic Drugs in Cancer Treatment
Current Pharmaceutical Design Focal Adhesion Kinase as a Therapeutic Target of Bortezomib
Anti-Cancer Agents in Medicinal Chemistry Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Current Drug Targets Structural Modeling Studies of Aldehyde Dehydrogenase X: Insights into Key Interactions in the Tetrameric Assembly of the Isoenzyme
Protein & Peptide Letters Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Current Medicinal Chemistry - Anti-Cancer Agents Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine De Novo DNMTs and DNA Methylation: Novel Insights into Disease Pathogenesis and Therapy from Epigenomics
Current Pharmaceutical Design